Pharmaceutical composition for therapy of interstitial cystitis

Details Pharmaceutical composition for therapy of interstitial cystitis Pharmaceutical composition for therapy of interstitial cystitis

A - Human Necessities

61

K

A61K 31/4725 (2006.01) A61P 13/02 (2006.01) A61P 13/10 (2006.01) C07D 453/02 (2006.01)

Patent

CA 2449922

A depressant of capsaicin-sensitive sensory nerve, containing quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetra- hydroisoquinoline-2-carboxylate or a salt thereof as an active ingredient, specifically a therapeutic drug of interstitial cystitis, hypersensitive disorder of the lower urinary tract, and/or abacterial prostatitis.

L'invention concerne un neurodépresseur sensoriel sensible à la capsicine contenant du quinuclidine-3'-yl 1-phényl-1,2,3,4-tétrahydroisoquinoline-2-carboxylate ou un sel de celui-ci comme principe actif. La composition selon l'invention est un médicament permettant de traiter une maladie urologique choisie dans le groupe constitué par la cystite interstitielle, l'hyperesthésie dans le tractus urinaire inférieur et la prostatite.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for therapy of interstitial cystitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for therapy of interstitial cystitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for therapy of interstitial cystitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1574695